Navigation Links
Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry
Date:5/15/2012

siness - Buyer Responses (%), 2012

Figure 45: Actions to Maintain and Secure Buyer Business by Company Region (%), 2012

Figure 46: Actions to Maintain and Secure Buyer Business by Company Turnover (%), 2012

Figure 47: Actions to Maintain and Secure Buyer Business by Purchasing Decision Authority (%), 2012

Figure 48: Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers (%), 2010–2012

Figure 49: Annual Marketing Budgets by Region: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 50: Annual Marketing Budgets by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 51: Planned Change in Marketing Expenditure: Global Pharmaceutical Suppliers (%), 2010–2012

Figure 52: Planned Change in Marketing Expenditure Levels by Region (%), 2012

Figure 53: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2012

Figure 54: Future Investment by Media Channels : Global Pharmaceutical Industry Suppliers (%), 2012

Figure 55: Global Pharmaceutical Industry Suppliers: Investment in Media Channels by Region (%), 2012

Figure 56: Global Pharmaceutical Industry Suppliers: Investment in Media Channels by Turnover (%), 2012

Figure 57: Investment in Marketing and Sales: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 58: Investment in Marketing and Sales by Region: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 59: Investment in Marketing and Sales by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 60: Key Marketing Aims: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 61: Key Marketing Aims by Region: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 62: Key Marketing Aims by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 63: Key Marketing Aims by Revenue Growth Expectations: Global Pharmaceutical Industry Suppliers (%
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013  Decision Resources, one ... firms for pharmaceutical and healthcare issues, finds ... on key efficacy endpoints, including overall survival ... most influence over surveyed U.S. and European ... positive, HER2-negative breast cancer. The two novel ...
(Date:5/21/2013)... , May 21, 2013 iHealth ... manufacture of wireless personal healthcare products and a ... reach, announcing the release of two new fitness ... pressure monitors and scales: the Wireless Pulse Oximeter ... (Photo: http://photos.prnewswire.com/prnh/20130521/SF17618 ) iHealth ...
(Date:5/21/2013)... FREDERICK, Md. , May 21, 2013 /PRNewswire/ ... inexpensive, disposable drug-free consumer electronic devices, announced that ... is presenting today to the FDA,s Medical Advisory ... reclassifying the company,s products for over the counter ... the FDA developed its medical device classification schema," ...
Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2iHealth Lab adds new products and partners to mobile personal healthcare offering 2iHealth Lab adds new products and partners to mobile personal healthcare offering 3BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3
... 26 Todd Bluedorn, chief executive officer of Lennox International ... at the J.P. Morgan HVAC Conference on Thursday, May 28 ... presentation materials can be accessed on the company,s website at ... archived for 60 days. The webcast can also be ...
... Health, Inc. (TH) is pleased to announce its involvement in ... Komen Foundation. TH,s collaborator, Duke University , was ... million of investment by the foundation in 2009 to further ... cancer.The Susan G. Komen for the Cure(R) is a nonprofit ...
Cached Medicine Technology:Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R) 2Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R) 3
(Date:5/21/2013)... A new study appearing in the current ... cells harvested from fat (adipose) are more potent than ... the body’s immune system. , The finding could ... adipose tissue-derived stem cells (AT-SCs) are far more plentiful ... and can be collected from waste material from liposuction ...
(Date:5/21/2013)... Australia (PRWEB) May 22, 2013 About ... made the Fertility Clinics industry one of ... industry assists patients who are unable to conceive naturally ... and popular of which is in-vitro fertilisation (IVF) cycles. ... IVF cycles in Australia has increased by 4.4% per ...
(Date:5/21/2013)... in St. Louis announced today that it is ... by the Bill & Melinda Gates Foundation. Tae ... & chemical engineering, will pursue an innovative global ... of Parasite Eggs by Probiotic Organisms." , Grand ... ideas that can break the mold in how ...
(Date:5/21/2013)... Dayton, OH (PRWEB) May 21, 2013 ... is associated with an increased risk for CKD progression ... at Dayton Children’s Hospital and Johns Hopkins University has ... disease who are exposed to secondhand smoke. , ... years is the first study of the effect of ...
(Date:5/21/2013)... Columbia, MO (PRWEB) May 21, 2013 The ... 2,500 athletes and coaches from across the state to Columbia. ... campuses of the University of Missouri and Columbia College, and ... , The State Summer Games officially kick off at 7:30 ... Ceremony will feature a Go Wild! theme, the Parade of ...
Breaking Medicine News(10 mins):Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 2Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 3Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Gates Fellowship addresses parasite infection in developing world 2Health News:Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study 2Health News:Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study 3Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 2Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 3
... demands the immediate release of three Sri Lankan physicians whom the Sri ... ... (Vocus) May 18, 2009 -- Physicians for Human Rights (PHR) ... Lankan Army (SLA) detained on May 16, 2009. A Minister of Health ...
... (Nasdaq: BJGP ) ("BMP Sunstone" or the "Company"), today ... , Financial Highlights from the First Quarter Ended ... to $39.3 million from $18.1 million in, ... profit increased to $20.7 million from $7.7 million in the prior, ...
... 18 Beckman Coulter, Inc. (NYSE: BEC ... that simplify, automate and innovate complex biomedical testing, today ... of its common stock, to finance in part ... of Olympus Corporation,s Life Science business, or the acquisition. ...
... The Quigley Corporation, (Nasdaq: QG L ... , today announced an update on the Company,s ... announcement regarding the unexpected positive finding for its QR-333 ... 11b clinical trial. While the complete statistical results of ...
... suggests that evolution needed only a few genetic changes to ... comparing the fetal development of the eye of the owl ... only a minor difference in the timing of cell proliferation ... of eyes.The findings help scientists understand how a structure as ...
... Cincinnati (UC) cancer and cell biologists have identified a ... prostate cancers. , In a preclinical study ... that simultaneous inactivation of two particular genesknown as ... cancer tumors in mice. , "We knew that ...
Cached Medicine News:Health News:Physicians for Human Rights Calls for the Release of Sri Lankan Doctors 2Health News:Physicians for Human Rights Calls for the Release of Sri Lankan Doctors 3Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 2Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 3Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 4Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 5Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 6Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 7Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 8Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 9Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 10Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 11Health News:Beckman Coulter, Inc. Announces Common Stock Offering 2Health News:Beckman Coulter, Inc. Announces Common Stock Offering 3Health News:The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure 2Health News:The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure 3Health News:The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure 4Health News:New Insight Into Primate Eye Evolution 2Health News:New Insight Into Primate Eye Evolution 3Health News:New Insight Into Primate Eye Evolution 4Health News:Research reveals molecular pathway behind invasive prostate cancers 2
MT-BT-5011-25 Prostate seeding needle (set of 25 unloaded needles).,MT-BT-5011-P Prostate seeding needle, pre-plugged and pre-sterilized, unloaded or for use with MEDTECs ASAP™ pre-load seedin...
... offers five classes of resectoscope electrodes ... loops, knife, roller bar & ball, ... only electrodes specifically integrated into the ... removal with minimal bleeding, increased visibility, ...
... and MRO™-2005 Rigid Percutaneous Nephroscopes combine ... throughput capacity with proven MRO performance. ... with small size sheaths. The MRO™-20 ... easy positioning during percutaneous procedures. The ...
... Resectoscope is based on the award winning ... the surgeon to perform TURis - resection ... element, HF cable and electrodes, Olympus OES ... in saline, supporting both, standard TUR and ...
Medicine Products: